Drawing based on the label description. No photo yet.
“Dapagliflozin and metformin HCl extended-release tablets 10/1000 mg:Yellow to dark yellow colored oval shaped, beveled edge, biconvex, film-coated tablets debossed with "DM4" on one face and plain on other face”
DM4 pill
Pill with imprint DM4 is yellow, oval, 21 mm and has been identified as Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg. It is used for type 2 diabetes and heart failure. It is supplied by Micro Labs Limited.
Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg
- Imprint
- DM4
- Strength
- Dapagliflozin 10 mg / Metformin Hydrochloride 1000 mg
- Used for
- Type 2 diabetes and heart failure
- Color
- Yellow
- Shape
- Oval
- Size
- 21 mm
- Score
- No score line
- Form
- Tablet, film coated, extended release
- Manufacturer
- Micro Labs Limited
- Drug class
- Diabetes medicine (SGLT2 inhibitor)
- NDC
- 42571-323, 42571-323-30, 42571-323-90, 42571-323-04
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Dapagliflozin and Metformin used for?
Dapagliflozin and Metformin is used for type 2 diabetes and heart failure.
- Medicine type
- Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label
Dapagliflozin and metformin hydrochloride extended-release tablets are a combination of dapagliflozin and metformin hydrochloride (HCl) extended-release, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dapagliflozin, when used as a component of dapagliflozin and metformin hydrochloride extended-release tablets, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:
- Sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression.
- CV death, hospitalization for heart failure, and urgent heart failure visit in patients with heart failure.
- Hospitalization for heart failure in patients with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.
Limitations of Use
- Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
- Because of the metformin hydrochloride component, the use of dapagliflozin and metformin hydrochloride extended-release tablets is limited to patients with type 2 diabetes mellitus for all indications.
- Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive therapy for kidney disease. Dapagliflozin and metformin hydrochloride extended-release tablets are not expected to be effective in these populations.
Pediatric use information is approved for AstraZeneca AB’s Xigduo ® XR (dapagliflozin and metformin hydrochloride) Extended-Release Tablets. However, due to AstraZeneca AB’s marketing exclusivity rights, this drug product is not labeled with that information.
From the FDA-approved label on DailyMed (published Sep 24, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows DM4 and the other side is plain.
- It is yellow, oval, 21 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Dapagliflozin, Metformin Hydrochloride
Inactive: Microcrystalline Cellulose, Anhydrous Lactose, Crospovidone, Polysorbate 80, Silicon Dioxide, Magnesium Stearate, Hypromellose, Unspecified, Talc, Polyethylene Glycol, Unspecified, Ferric Oxide Yellow, Povidone K30, Glyceryl Dibehenate, Polyvinyl Alcohol, Unspecified, Titanium Dioxide, Ferrosoferric Oxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G
Colestipol Hydrochloride 1 g
Yellow, oval, 21 mm
Used for high cholesterol and high triglycerides
-
656 P
Zileuton 600 mg
Yellow, oval, 20 mm
Used for asthma
- CSN50 Cyclosporine 50 mg Yellow, oval, 20 mm Used for myasthenia gravis and rheumatoid arthritis
- SM1 Saxagliptin and Metformin Hydrochloride 2.5 mg / 1000 mg Yellow, oval, 21 mm Used for type 2 diabetes
- I C Valsartan 320 mg Yellow, oval, 20 mm Used for high blood pressure and heart failure
- RAN1000 Ranolazine 1000 mg Yellow, oval, 22 mm Used for chest pain (angina)
Other Dapagliflozin and Metformin pills
- 1073 10 1000 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- N 25 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- D M 10 1000 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- MD4 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Brown, oval, 20 mm Used for type 2 diabetes and heart failure
- RL 61 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- L111 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- F26 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- N 19 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, capsule, 20 mm Used for type 2 diabetes and heart failure